Spatial discrimination in patients with MSA, PSP, DIP, and VP with pain

Area of Science:

• Neurology
• Pain Medicine
• Neuroscience

Background:

• Pain is a prevalent symptom in Parkinson's disease (PD) and other parkinsonian disorders.
• Abnormal sensory scaling function has been linked to pain in PD, but its role in other parkinsonism-related conditions is unclear.

Purpose of the Study:

• To investigate the role of sensory scaling function in the development of pain in patients with multiple system atrophy (MSA), progressive supranuclear palsy (PSP), drug-induced parkinsonism (DIP), and vascular parkinsonism (VP).

Main Methods:

• 127 patients with parkinsonism were screened; 79 were included (23 MSA, 10 PSP, 28 DIP, 18 VP).
• Patients in each group were categorized as with or without pain.
• Sensory detection threshold (SDT) was measured to assess scaling function.

Main Results:

• Pain prevalence varied across conditions: MSA (73.9%), PSP (50.0%), DIP (67.9%), and VP (66.7%).
• No significant differences in mean SDT were found between patients with and without pain in any parkinsonian disorder.
• The number of patients with unmeasurable SDT also did not differ between pain groups.

Conclusions:

• This study found no evidence supporting a role for sensory scaling function in pain development across various parkinsonian disorders.
• Findings suggest that mechanisms other than abnormal scaling function contribute to pain in MSA, PSP, DIP, and VP.